Atea Pharmaceuticals, Inc.AVIRNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank14
Studio
Year-over-Year Change

Enterprise value to sales ratio

Latest
0.00
↓ 100% vs avg
Percentile
P14
Within normal range
Average
6.66
Historical baseline
PeriodValueYoY Change
20250.00-
20240.00-
20230.00-
20220.00+100.0%
2021-0.07-100.1%
202053.34-
20190.00-
20180.00-